Crohn's disease: open trials in Israel

31 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Assuta Ashdod Medical Center, Ashdod · Rambam Health Care Campus, Haifa · Edith Wolfson Medical Center, Holon · Shaare Zedek Medical Center, Jerusalem · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Sourasky Medical Center, Tel Aviv · Yitzhak Shamir Medical Center, Tsrifin
Registry updated 2026-11-04
NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
Assuta Ashdod Medical Center, Ashdod · Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Yitzhak Shamir Medical Center, Tsrifin
Registry updated 2026-11-04
NCT07483099
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
Assuta Ashdod Medical Center, Ashdod · Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Yitzhak Shamir Medical Center, Tsrifin
Registry updated 2026-11-04
NCT05923073
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Soroka University Medical Center, Beersheba · Shamir Medical Center Assaf Harofeh, Be’er Ya‘aqov · Shaare Zedek Medical Center, Jerusalem · Hadassah medical Center, Jerusalem · Schneider Children's Medical Center, Petah Tikva · Kaplan Medical Center, Rehovot
Registry updated 2026-11-03
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hadassah Ein-Qarem Medical Center, Jerusalem
Registry updated 2026-11-03
NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Ha'Emek Medical Center, Afula · Assuta MC, Ashdod · Shamir Medical Center Assaf Harofeh, Be’er Ya‘aqov · Bnai Zion Medical Center, Haifa · Rambam Medical Center, Haifa · Shaare Zedek Medical Center, Jerusalem · Galilee Medical Center, Nahariya · Rabin Medical Center, Petah Tikva · Chaim Sheba Medical Center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-03
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Assuta Medical Center, Ashdod · Rambam Medical Center, Haifa · Bnai Zion Medical Center, Haifa · Wolfson Medical Center, Holon/Tel Aviv · Meir Medical Center, Kfar Saba · Galilee Medical Center, Nahariya · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv · Shaare Zedek Medical Center, Yeruham
Registry updated 2026-11-03
NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Takeda
Assuta Ashdod Medical Center, Ashdod · Soroka Mc, Beersheba · Digestive Disease Institute, Shaare Zedek Medical Center, Jerusalem · Meir Medical Center, Kfar Saba · The Chaim Sheba Medical Center, Ramat Gan
Registry updated 2026-11-02
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Emek Medical Center (Site 1206), Afula · Barzilai Medical Center (Site 1209), Ashkelon · Rambam Health Care Campus (Site 1201), Haifa · Bnai Zion Medical Center (Site 1203), Haifa · Edith Wolfson Medical Center (Site 1204), Holon · Shaare Zedek Medical Center (Site 1208), Jerusalem · Meir Medical Center. (Site 1202), Kfar Saba · Rabin Medical Center (Site 1207), Petah Tikva · Sheba Medical Center (Site 1200), Ramat Gan
Registry updated 2026-11-02
NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Trial Treatment · Phase 2 · AbbVie
Assuta Ashdod Medical Center /ID# 280535, Ashdod
Registry updated 2026-10-27
NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hadassah medical Center, Jerusalem · Shaare Zedek Medical Center, Jerusalem
Registry updated 2026-10-26
NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Afula · Ashkelon · Beersheba · Jerusalem · Nahariya · Petah Tikva · Tel Aviv
Registry updated 2026-10-21
NCT07184944
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Jerusalem · Tel Aviv
Registry updated 2026-10-21
NCT05995353
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · AbbVie
Shaare Zedek Medical Center /ID# 254951, Jerusalem · Schneider Children's Medical Center /ID# 254950, Petah Tikva
Registry updated 2026-10-20
NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Soroka University Medical Centre, Beersheba · Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · Chaim Sheba Medical Center, Ramat Gan
Registry updated 2026-10-16
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
Soroka Medical Center, Beersheba · Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Schneider Children's Medical Center, Petah Tikva · Yitzhak Shamir Medical Center, Tsrifin
Registry updated 2026-10-07
NCT05509777
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Trial Treatment · Phase 3 · Eli Lilly and Company
Soroka Medical Center, Beersheba · Shamir Medical Center (Assaf Harofeh), Israel · Hadassah University Hospital - Ein Kerem, Jerusalem · Shaare Zedek, Jerusalem · Schneider Children's Medical Center, Petah Tikva · Kaplan Medical Center, Pediatric Gastroenterology Dept., Rehovot
Registry updated 2026-10-07
NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Trial Treatment · Phase 2 · AbbVie
Soroka Medical Center /ID# 267235, Beersheba · Rambam Health Care Campus- Haifa /ID# 267641, Haifa · Edith Wolfson Medical Center /ID# 267640, Holon · Tel Aviv Sourasky Medical Center /ID# 267307, Tel Aviv
Registry updated 2026-09-25
NCT06494826
Decoding the Clinical Impact of Host and Microbial Intestinal Proteomic Landscape in Crohn's Disease
Research · Weizmann Institute of Science
Emek Medical Center, Afula
Registry updated 2026-09-15
NCT05599347
Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
Trial Treatment · Phase 2 · Rambam Health Care Campus
Soroka University Medical Center, Beersheba · Rambam Health Care Campus, Haifa · Carmel Medical Center, Haifa · Bnei Zion, Haifa · Wolfson Medical Center, Holon · Hadassah medical Center, Jerusalem · Shaare Zedek, Jerusalem · Zvulun, Kiryat Bialik · Rabin Medical Center, Petah Tikva
Registry updated 2026-07-29
NCT07649408
Impact of Advanced Crohn's Disease Therapies on Sleep Quality
Research · Shmuel Kivity, MD
Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-06-16
NCT07644117
Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
Research · Shmuel Kivity, MD
Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-06-12
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Soroka Medical Center, Beersheba · Rambam Health Care Campus (RHCC), Haifa · Meir Medical Center, Kfar Saba · Rabin Medical Center - Beilinson Campus (Beilinson and Hasharon Hospital), Petah Tikva · The Tel Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-05-27
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Soroka University Medical Centre, Beersheba · Carmel Medical Center, Haifa · Rambam Health Care Campus PPDS, Haifa · Tel Aviv Sourasky Medical Center Ichilov - PPDS, Jerusalem · Hadassah Medical Center- Ein Kerem - PPDS, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Schneider Childrens Medical Center of Israel Petah Tikvah PIN, Petah Tikva
Registry updated 2026-05-07
NCT04779320
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Soroka University Medical Centre, Beersheba · Carmel Medical Center, Haifa · Rambam Medical Center - PPDS, Haifa · Hadassah Medical Center PPDS -, Jerusalem · Tel Aviv Sourasky Medical Center PPDS, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Schneider Childrens Medical Center of Israel Petah Tikvah PIN, Petah Tikva
Registry updated 2026-05-05

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error